[1]王海莹,张子朋,吕冰.高能量胸腰椎骨折围手术期下肢深静脉血栓形成的危险因素分析[J].中医正骨,2022,34(02):24-30.
　WANG Haiying,ZHANG Zipeng,LYU Bing.Analysis of risk factors for lower limb deep venous thrombosis in the perioperative period of high-energy thoracolumbar fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2022,34(02):24-30.
点击复制

高能量胸腰椎骨折围手术期下肢深静脉血栓形成的危险因素分析()
分享到：

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第34卷
期数:
2022年02期
页码:
24-30
栏目:
临床研究
出版日期:
2022-02-20

文章信息/Info

Title:
Analysis of risk factors for lower limb deep venous thrombosis in the perioperative period of high-energy thoracolumbar fractures
作者:
王海莹; 张子朋; 吕冰
保定市第一中心医院,河北 保定 071000
Author(s):
WANG Haiying; ZHANG Zipeng; LYU Bing
Baoding No.1 Central Hospital,Baoding 071000,Hebei,China
关键词:
脊柱骨折;  胸椎;  腰椎;  静脉血栓形成;  危险因素;  Logistic模型
Keywords:
spinal fractures;  thoracic vertebrae;  lumbar vertebrae;  venous thrombosis;  risk factors;  Logistic models
摘要:
目的:探讨高能量胸腰椎骨折围手术期下肢深静脉血栓形成(deep venous thrombosis,DVT)的危险因素。方法:选择429例采用手术治疗的高能量胸腰椎骨折患者,从病历系统中提取年龄、性别、体质量指数、是否合并高血压、是否合并糖尿病、是否合并冠心病、术前和术后美国脊柱损伤协会(American Spinal Injury Association,ASIA)脊髓损伤神经功能分级、骨折至手术时间、卧床时间、D-二聚体血浆含量、纤维蛋白原血浆含量、凝血酶时间(thrombin time,TT)、活化部分促凝血酶原激酶时间(activated partial thromboplastin time,APTT)、凝血酶原时间(prothrombin time,PT)、高密度脂蛋白(high density lipoprotein,HDL)血清含量、低密度脂蛋白(low density lipoprotein,LDL)血清含量、血小板计数、红细胞体积分布宽度(red cell volume distribution width,RDW)变异系数、手术时间、出血量、补液量、是否输血、引流量等信息。按照术前是否发生下肢DVT将患者分为术前下肢DVT组和术前无下肢DVT组,按照术后是否发生下肢DVT将患者分为术后下肢DVT组和术后无下肢DVT组。分别对术前下肢DVT组和术前无下肢DVT组、术后下肢DVT组和术后无下肢DVT组患者的相关信息进行单因素分析,然后对其中组间差异有统计学意义的因素分别进行多因素Logistic回归分析。结果:术前下肢DVT组62例,术前无下肢DVT组367例。2组患者的年龄、术前ASIA脊髓损伤神经功能分级、骨折至手术时间、D-二聚体血浆含量、RDW变异系数比较,组间差异均有统计学意义(t=2.960,P=0.004; χ2=12.161,P=0.007; t=9.040,P=0.000; Z=-6.771,P=0.000; Z=-7.030,P=0.000); 2组患者的性别、体质量指数、是否合并高血压、是否合并糖尿病、是否合并冠心病、纤维蛋白原血浆含量、TT、APTT、PT、HDL血清含量、LDL血清含量、血小板计数比较,组间差异均无统计学意义(χ2=0.104,P=0.747; t=0.734,P=0.460; χ2=0.042,P=0.838; χ2=0.762,P=0.383; χ2=0.449,P=0.503; Z=-0.640,P=0.522; Z=-1.250,P=0.211; Z=-0.203,P=0.839; Z=-1.691,P=0.091; Z=-1.146,P=0.252; Z=-0.839,P=0.401; Z=-1.589,P=0.112)。Logistic回归分析结果显示,骨折至手术时间、术前ASIA脊髓损伤神经功能分级(A级)、D-二聚体血浆含量是高能量胸腰椎骨折术前发生下肢DVT的危险因素(β=0.137,P=0.001,OR=1.147; β=2.117,P=0.000,OR=8.308; β=0.187,P=0.000,OR=1.205)。术后下肢DVT组83例,术后无下肢DVT组346例。2组患者的年龄、术后ASIA脊髓损伤神经功能分级、卧床时间、D-二聚体血浆含量、纤维蛋白原血浆含量、手术时间、出血量、补液量、是否输血、引流量比较,组间差异均有统计学意义(t=4.780,P=0.000; χ2=15.902,P=0.001; Z=-4.422,P=0.000; Z=-7.078,P=0.000; Z=-8.486,P=0.000; Z=-4.692,P=0.000; Z=-4.346,P=0.000; Z=-2.628,P=0.009; χ2=10.298,P=0.005; Z=-2.777,P=0.005); 2组患者的性别、体质量指数、是否合并高血压、是否合并糖尿病、是否合并冠心病、TT、APTT、PT比较,组间差异均无统计学意义(χ2=0.892,P=0.345; t=1.550,P=0.122; χ2=1.212,P=0.271; χ2=0.004,P=0.948; χ2=0.049,P=0.825; Z=-0.870,P=0.384; Z=-0.637,P=0.524; Z=-0.228,P=0.819)。Logistic回归分析结果显示,年龄、术后ASIA脊髓损伤神经功能分级(A级)、卧床时间、D-二聚体血浆含量、纤维蛋白原血浆含量、输血是高能量胸腰椎骨折术后发生下肢DVT的危险因素(β=0.041,P=0.006,OR=1.042; β=2.239,P=0.000,OR=10.374; β=0.159,P=0.008,OR=1.172; β=0.591,P=0.000,OR=1.805; β=0.428,P=0.000,OR=1.535; β=0.708,P=0.036,OR=2.030)。结论:骨折至手术时间、术前ASIA脊髓损伤神经功能分级(A级)、D-二聚体血浆含量是高能量胸腰椎骨折术前发生下肢DVT的危险因素; 年龄、术后ASIA脊髓损伤神经功能分级(A级)、卧床时间、D-二聚体血浆含量、纤维蛋白原血浆含量、输血是术后发生下肢DVT的危险因素。
Abstract:
Objective:To explore the risk factors for lower limb deep venous thrombosis(LDVT)in the perioperative period of high-energy thoracolumbar fractures.Methods:Four hundred and twenty-nine patients who underwent surgery for treatment of high-energy thoracolumbar fractures were selected,and the information including age,gender,body mass index(BMI),whether combined with hypertension,whether combined with diabetes,whether combined with coronary heart disease(CHD),preoperative and postoperative American Spinal Injury Association(ASIA)neurological classification of spinal cord injury,duration from fracture to surgery,bed rest time,plasma D-dimer level,plasma fibrinogen level,thrombin time(TT),activated partial thromboplastin time(APTT),prothrombin time(PT),serum high density lipoprotein(HDL)level,serum low density lipoprotein(LDL)level,platelet count,coefficient of variation of red cell volume distribution width(RDW-CV),operative time,blood loss,volume of intravenous fluid infusion,blood transfusion or not and drainage volume was extracted from the Electronic Medical Record System(EMRS).The patients were divided into preoperative LDVT group(62 cases)and preoperative non-LDVT group(367 cases)according to whether LDVT was found before the surgery,and the patients were divided into postoperative LDVT group(83 cases)and postoperative non-LDVT group(346 cases)according to whether LDVT was found after the surgery.Single-factor analysis was performed on the information of patients in preoperative LDVT group and preoperative non-LDVT group,and those in postoperative LDVT group and postoperative non-LDVT group respectively,followed by multi-factor logistic regression analysis on the factors with significant differences between groups.Results:The differences were statistically significant between preoperative LDVT group and preoperative non-LDVT group in age,preoperative ASIA neurological classification of spinal cord injury,duration from fracture to surgery,plasma D-dimer level and RDW-CV(t=2.960,P=0.004; χ2=12.161,P=0.007; t=9.040,P=0.000; Z=-6.771,P=0.000; Z=-7.030,P=0.000).There was no statistical difference in gender,BMI,whether combined with hypertension,whether combined with diabetes,whether combined with CHD,plasma fibrinogen level,TT,APTT,PT,serum level of HDL,serum level of LDL and platelet count between preoperative LDVT group and preoperative non-LDVT group(χ2=0.104,P=0.747; t=0.734,P=0.460; χ2=0.042,P=0.838; χ2=0.762,P=0.383; χ2=0.449,P=0.503; Z=-0.640,P=0.522; Z=-1.250,P=0.211; Z=-0.203,P=0.839; Z=-1.691,P=0.091; Z=-1.146,P=0.252; Z=-0.839,P=0.401; Z=-1.589,P=0.112).The results of logistic regression analysis revealed that the duration from fracture to surgery,preoperative ASIA neurological classification of spinal cord injury(Grade A)and plasma D-dimer level were the risk factors for LDVT in patients with high-energy thoracolumbar fractures before the surgery(β=0.137,P=0.001,OR=1.147; β=2.117,P=0.000,OR=8.308; β=0.187,P=0.000,OR=1.205).The differences were statistically significant between postoperative LDVT group and postoperative non-LDVT group in age,postoperative ASIA neurological classification of spinal cord injury,bed rest time,plasma D-dimer level,plasma fibrinogen level,operative time,blood loss,volume of intravenous fluid infusion,blood transfusion or not and drainage volume(t=4.780,P=0.000; χ2=15.902,P=0.001; Z=-4.422,P=0.000; Z=-7.078,P=0.000; Z=-8.486,P=0.000; Z=-4.692,P=0.000; Z=-4.346,P=0.000; Z=-2.628,P=0.009; χ2=10.298,P=0.005; Z=-2.777,P=0.005).There was no statistical difference in gender,BMI,whether combined with hypertension,whether combined with diabetes,whether combined with CHD,TT,APTT and PT between postoperative LDVT group and postoperative non-LDVT group(χ2=0.892,P=0.345; t=1.550,P=0.122; χ2=1.212,P=0.271; χ2=0.004,P=0.948; χ2=0.049,P=0.825; Z=-0.870,P=0.384; Z=-0.637,P=0.524; Z=-0.228,P=0.819).The results of logistic regression analysis revealed that the age,postoperative ASIA neurological classification of spinal cord injury(Grade A),bed rest time,plasma D-dimer level,plasma fibrinogen level and blood transfusion were the risk factors for LDVT in patients with high-energy thoracolumbar fractures after the surgery(β=0.041,P=0.006,OR=1.042; β=2.239,P=0.000,OR=10.374; β=0.159,P=0.008,OR=1.172; β=0.591,P=0.000,OR=1.805; β=0.428,P=0.000,OR=1.535; β=0.708,P=0.036,OR=2.030).Conclusion:For patients with high-energy thoracolumbar fractures,the duration from fracture to surgery,preoperative ASIA neurological classification of spinal cord injury(Grade A)and plasma D-dimer level are the risk factors for LDVT before the surgery; while the age,postoperative ASIA neurological classification of spinal cord injury(Grade A),bed rest time,plasma D-dimer level,plasma fibrinogen level and blood transfusion are the risk factors for LDVT after the surgery.

参考文献/References:

[1] WANG P,KANDEMIR U,ZHANG B,et al.Incidence and risk factors of deep vein thrombosis in patients with pelvic and acetabular fractures[J/OL].Clin Appl Thromb Hemost,2019,25[2021-06-08].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714909/.
[2] KARCUTSKIE C A,MEIZOSO J P,RAY J J,et al.Associ-ation of mechanism of injury with risk for venous thrombo-embolism after trauma[J].JAMA Surg,2017,152(1):35-40.
[3] ZHANG W,HUAI Y,WANG W,et al.A Retrospective cohort study on the risk factors of deep vein thrombosis(DVT)for patients with traumatic fracture at Honghui Hospital[J/OL].BMJ Open,2019,9(3)[2021-06-08].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443064/.
[4] XING F,LI L,LONG Y,et al.Admission prevalence of deep vein thrombosis in elderly Chinese patients with hip fracture and a new predictor based on risk factors for thrombosis screening[J].BMC Musculoskelet Disord,2018,19(1):444.
[5] MARKOVIC-DENIC L,ZIVKOVIC K,LESIC A,et al.Risk factors and distribution of symptomatic venous thromboembolism in total hip and knee replacements:prospective study[J].Int Orthop,2012,36(6):1299-1305.
[6] KRAUSS E S,SEGAL A,CRONIN M,et al.Implementation and validation of the 2013 Caprini score for risk stratifi-cation of arthroplasty patients in the prevention of venous thrombosis[J/OL].Clin Appl Thromb Hemost,2019,25[2021-06-08]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714918/.
[7] GHOBRIAL G M,MAULUCCI C M,MALTENFORT M,et al.Operative and nonoperative adverse events in the management of traumatic fractures of the thoracolumbar spine:a systematic review[J].Neurosurg Focus,2014,37(1):E8.
[8] ALVARADO A M,PORTO G B F,WESSELL J,et al.Venous thromboprophylaxis in spine surgery[J].Global Spine J,2020, 10(1 Suppl):S65-S70.
[9] LEON L,RODRIGUEZ H,TAWK R G,et al.The prophylactic use of inferior vena cava filters in patients undergoing high-risk spinal surgery[J].Ann Vasc Surg,2005,19(3):442-447.
[10] SEBASTIAN A S,CURRIER B L,KAKAR S,et al.Risk factors for venous thromboembolism following thoracolumbar surgery:analysis of 43,777 Patients from the American College of Surgeons National Surgical Quality Improvement Program 2005 to 2012[J].Global Spine J,2016,6(8):738-743.
[11] AL-DUJAILI T M,MAJER C N,MADHOUN T E,et al.Deep venous thrombosis in spine surgery patients:incidence and hematoma formation[J].Int Surg,2012,97(2):150-154.
[12] WANG H,PEI H,DING W,et al.Risk factors of postoperative deep vein thrombosis(DVT)under low molecular weight heparin(LMWH)prophylaxis in patients with thoracolumbar fractures caused by high-energy injuries[J].J Thromb Thrombolysis,2021,51(2):397-404.
[13] ROTA E,VALLISA D,MORELLI N,et al.Iatrogenic coagulopathy and the development of posterior reversible encephalopathy syndrome after l-asparaginase chemotherapy[J].J Clin Imaging Sci,2016,6:7.
[14] ZHANG B F,WEI X,HUANG H,et al.Deep vein thrombosis in bilateral lower extremities after hip fracture:a retrospective study of 463 patients[J].Clin Interv Aging,2018,13:681-689.
[15] XIA Z N,XIAO K,ZHU W,et al.Risk assessment and management of preoperative venous thromboembolism following femoral neck fracture[J].J Orthop Surg Res,2018,13(1):291.
[16] SABERI H,GHAJARZADEH M.Emotional intelligence in patients with spinal cord injury(SCI)[J]. Iran J Public Health,2017,46(5):677-681.
[17] SONG K,YAO Y,RONG Z,et al.The preoperative incidence of deep vein thrombosis(DVT)and its correlation with postoperative DVT in patients undergoing elective surgery for femoral neck fractures[J].Arch Orthop Trauma Surg,2016,136(10):1459-1464.
[18] KE L,CUI S,CHEN S,et al.Dynamics of D-dimer in non-small cell lung cancer patients receiving radical surgery and its association with postoperative venous thromboembolism[J].Thorac Cancer,2020,11(9):2483-2492.
[19] JIANG T,SONG K,YAO Y,et al.Perioperative allogenic blood transfusion increases the incidence of postoperative deep vein thrombosis in total knee and hip arthroplasty[J].J Orthop Surg Res,2019,14(1):235.
[20] YAN Y,ZHANG B,YANG J,et al.The perioperative deep vein thrombosis in lower extremities in patients with pelvic fracture:a case-control study[J/OL].Clin Appl Thromb Hemost,2021,27[2021-06-12].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317243/.
[21] GOEL R,PATEL E U,CUSHING M M,et al.Association of perioperative red blood cell transfusions with venous thromboembolism in a north American registry[J].JAMA Surg,2018,153(9):826-833.

相似文献/References:

[1]许兵,叶小雨,王萧枫,等.小管径经皮椎体后凸成形术治疗 骨质疏松性椎体重度压缩骨折[J].中医正骨,2015,27(11):29.
[2]郭小伟,梅伟,潘玉林,等.一期后路病灶清除纳米仿生骨椎体支撑体植骨融合 内固定治疗胸腰椎结核[J].中医正骨,2015,27(07):66.
[3]谢小利,李晓程.经皮椎体后凸成形术治疗骨质疏松性椎体 压缩骨折的围手术期护理[J].中医正骨,2015,27(05):79.
[4]潘雄,刘其顺,应行,等.中药联合4步康复锻炼法对骨质疏松性椎体压缩 骨折患者生存质量的影响[J].中医正骨,2015,27(04):65.
[5]李格,梅伟,刘沛霖,等.骨质疏松性椎体压缩骨折经皮椎体成形术后邻近椎体再骨折的危险因素探讨[J].中医正骨,2016,28(06):18.
　LI Ge,MEI Wei,LIU Peilin,et al.Investigation on risk factors for adjacent vertebral refractures after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(02):18.
[6]梅 伟.胸腰椎骨折临床诊疗中的热点问题[J].中医正骨,2016,28(07):1.
[7]李英周,叶锋,王晓,等.后路撬拨植骨椎弓根螺钉内固定治疗胸腰椎骨折[J].中医正骨,2016,28(07):46.
[8]王军,陈哲,王硕凡.胸腰椎骨折椎体植骨材料的临床应用进展[J].中医正骨,2016,28(07):64.
[9]张旭桥,王晓晖,黄光明,等.生骨胶囊在经皮椎体强化术治疗老年骨质疏松性胸腰椎骨折中的应用研究[J].中医正骨,2016,28(11):21.
　ZHANG Xuqiao,WANG Xiaohui,HUANG Guangming,et al.Application of Shenggu Jiaonang(生骨胶囊)to the treatment of osteoporotic thoracolumbar vertebral fractures in the aged who received percutaneous vertebral augmentation[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(02):21.
[10]张 涛.常规抗骨质疏松疗法联合脉冲射频术和银质针松解术治疗骨质疏松性椎体压缩骨折[J].中医正骨,2017,29(04):74.
[11]邓红军.硫酸钙骨水泥椎体成形联合后路短节段椎弓根螺钉 内固定治疗创伤性胸腰椎骨折[J].中医正骨,2015,27(10):35.
[12]李鹏,徐世涛,谭磊.椎旁肌间隙入路伤椎单侧植骨内固定治疗 单节段胸腰椎骨折[J].中医正骨,2015,27(06):43.
[13]孙德舜,王小鹤,王晓燕,等.气囊托板复位配合骨伤复元汤口服治疗 胸腰椎单纯压缩骨折[J].中医正骨,2015,27(05):65.
[14]武祥仁,胡海涛,茅祖斌.经椎旁肌间隙入路伤椎植骨内固定治疗 无神经损伤的胸腰椎骨折[J].中医正骨,2015,27(03):56.
[15]刘杰,朱小龙,石晨.手法复位联合经皮椎体后凸成形术治疗胸腰椎压缩性骨折[J].中医正骨,2016,28(05):28.
[16]杨振国,王树强,范杰,等.钉棒系统复位内固定联合经椎弓根撬拨植骨术治疗胸腰椎压缩性骨折[J].中医正骨,2016,28(05):31.
[17]陈思凯,邢金明.骨水泥强化椎弓根螺钉内固定治疗老年胸腰椎压缩性骨折[J].中医正骨,2016,28(05):35.
[18]孙彦鹏,史相钦,马虎升,等.小开窗减压短力臂伤椎置钉复位内固定术治疗胸腰椎爆裂性骨折[J].中医正骨,2016,28(11):26.
[19]江涛,徐彪炳,党旗.后路经伤椎椎弓根置钉联合椎板开窗减压关节突间植骨融合治疗胸腰椎爆裂性骨折[J].中医正骨,2017,29(02):72.
[20]陈华,李宇卫,姜宏.非手术疗法治疗单纯性胸腰椎骨折的研究进展[J].中医正骨,2017,29(07):48.

备注/Memo

备注/Memo:
基金项目:保定市科技计划项目(2041ZF100)
通讯作者:吕冰 E-mail:742623134@qq.com
更新日期/Last Update: 2022-02-20